Developing nanosize carrier systems for Amphotericin‐B: A review on the biomedical application of nanoparticles for the treatment of leishmaniasis and fungal …

N Sharifi, Z Alitaneh, S Asadi, Z Vahidinia… - Biotechnology …, 2024 - Wiley Online Library
New formulations of Amphotericin‐B (Am‐B), the most popular therapeutic drug for many
human infections such as parasitic and fungal pathogens, are safe, economical, and …

Advances in nanotechnology for improving the targeted delivery and activity of amphotericin B (2011–2023): a systematic review

T Zadeh Mehrizi, N Mosaffa, M Vodjgani… - …, 2024 - Taylor & Francis
Amphotericin B (AmB) is a broad-spectrum therapeutic and effective drug, but it has serious
side effects of toxicity and solubility. Therefore, reducing its toxicity should be considered in …

Antimicrobial potential and protein binding affinity of a hybrid ternary nanocomposite matrix: Zinc oxide functionalization with poly (vinyl alcohol)-sulphonated …

SK Mustafa, N Omer, MMH Aljohani, AH Alessa… - Inorganic Chemistry …, 2024 - Elsevier
The present study focuses on the application of a ternary PVA/sGO/ZnO-NP/PP
nanocomposite as an antibacterial and antifungal agent. The process involved utilizing a …

Nanostructured lipid carriers as robust systems for lupeol delivery in the treatment of experimental visceral leishmaniasis

JA Jesus, TNF da Silva, IMO Sousa, AF Ferreira… - Pharmaceuticals, 2023 - mdpi.com
Leishmaniasis is a neglected tropical disease that affects millions of people around the
world. Available therapy causes severe side effects, has unacceptable prices for some …

Disclosing the Antifungal Mechanisms of the Cyclam Salt H4[H2(4-CF3PhCH2)2Cyclam]Cl4 against Candida albicans and Candida krusei

I Costa, I Lopes, M Morais, R Silva, F Remião… - International Journal of …, 2024 - mdpi.com
Mycoses are one of the major causes of morbidity/mortality among immunocompromised
individuals. Considering the importance of these infections, the World Health Organization …

[HTML][HTML] Efficacy of Diterpene Polyalthic Acid Combined with Amphotericin B against Leishmania amazonensis In Vitro

ACBB Candido, MC Pagotti, DA Santos, LAL Paula… - Pharmaceuticals, 2024 - mdpi.com
Background/Objectives: Leishmaniasis, a neglected disease caused by Leishmania spp.
including L. amazonensis, urgently requires new treatments. Polyalthic acid (PA), a natural …